Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028
Triton
Market Research’s report has concluded that North America’s DNA sequencing market
is likely to develop at a CAGR of 16.96% in the estimated years between 2021 and
2028.
Report scope can be customized per your requirements. Request For Customization
The
countries analyzed in this market include:
• The United States
• Canada
The
United States is home to a number of public and private companies that invest
in personalized medicine and associated research activities. The rising adoption
of developed technologies, government support, and favorable policies are
primarily driving the demand for DNA sequencing in the country. Various
government bodies, like the National Human Genome Research Institute (NHGRI),
support research in the area of human genome sequencing, allocating substantial
funds for this purpose. Further, these organizations support research studies
on the legal, social, and ethical implications of genome research. All these
factors are positively impacting the studied market’s growth.
For
instance, Harvard Pilgrim Health Care and Illumina Inc announced signing an agreement
in December 2020 to make the whole-genome sequencing (WGS) technology available
to some of the Harvard Pilgrim members. The program is aimed to leverage this
technology to support the faster diagnosis of genetic diseases in children. The
sequencing technology is expected to eliminate the long, costly diagnostic
processes and improve patient outcomes. In January 2020, Element Biosciences, a
San Diego-based biotech company, raised $80 million to accelerate the
development of its new platform for DNA sequencing. All these instances
indicate that the United States market for DNA sequencing will progress significantly in
the coming years.
Illumina
Inc develops, manufactures, and distributes products and solutions having applications
in multiple life science methods and procedures. The primary markets in which
the company operates include life sciences and clinical genomics. Illumina
offers a comprehensive range of products that help in multiple applications, like
advanced disease research, drug development, and molecular tests. The company generates
its major revenue from the sale of instruments and consumables it manufactures.
These products are used to analyze the genome at all levels of complexity. The
company also offers genotyping, whole-genome sequencing, and NIPT to conduct
whole-genome sequencing & microarray projects. Founded in 1998, Illumina
Inc is headquartered in San Diego, California.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.3. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. NORTH
AMERICA DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. NORTH
AMERICA DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. NORTH
AMERICA DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. NORTH
AMERICA DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. NORTH
AMERICA DNA SEQUENCING MARKET – COUNTRY OUTLOOK
7.1. THE
UNITED STATES
7.2. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: NORTH AMERICA DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA INSTRUMENTS &
CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA INSTRUMENTS &
CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA DNA
SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: NORTH AMERICA DNA
SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: NORTH AMERICA DNA
SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA NGS
MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA NGS
MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA NGS
MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA NGS
MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA NGS
MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA NGS
MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA NGS
MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA DNA
SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA DNA
SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA DNA
SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: NORTH AMERICA DNA
SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA DNA
SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA DNA
SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA DNA
SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA DNA
SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA DNA
SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028
(IN $ MILLION)
FIGURE 25: NORTH AMERICA DNA
SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA DNA
SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA DNA
SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: NORTH AMERICA DNA
SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: NORTH AMERICA DNA
SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: NORTH AMERICA DNA
SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: NORTH AMERICA DNA
SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: NORTH AMERICA DNA
SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: NORTH AMERICA DNA
SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $
MILLION)
FIGURE 34: NORTH AMERICA DNA
SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: NORTH AMERICA DNA
SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: NORTH AMERICA DNA
SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: NORTH AMERICA DNA
SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 38: NORTH AMERICA DNA
SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: NORTH AMERICA DNA
SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: NORTH AMERICA DNA
SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: NORTH AMERICA DNA
SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: THE UNITED STATES DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: CANADA DNA SEQUENCING
MARKET 2021-2028 (IN $ MILLION)